Baxano Surgical, Inc. (BAXS) was a big mover last session, as the company saw its shares rise nearly 11% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 8% in the past one-month time frame.
In the last 30 days, the company witnessed 2 downward estimate revisions and the Zacks Consensus Estimate of a loss widened, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
Baxano Surgical, Inc currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked players in the healthcare industry include Myriad Genetics Inc. MYGN, ANI Pharmaceuticals, Inc. ANIP and Aastrom Biosciences, Inc. ASTM all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ANI PHARMACEUT ANIP: Free Stock Analysis Report
AASTROM BIOSCI ASTM: Get Free Report
BAXANO SURGICAL (BAXS): Free Stock Analysis Report
MYRIAD GENETICS MYGN: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
